DL Chemical buying Houston's Kraton for $1.6 billion
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
DL Chemical is buying Kraton, a Houston-based petrochemical company, for $1.6 billion. The purchase was approved by the company’s board on Sept. 27.
The acquisition is expected to help DL Chemical expand its product lineup from polyethylene and polybutene to more value-added materials. It will also help DL Chemical gain access to more countries utilizing Kraton's sales and logistics networks.
“DL Chemical plans to commercialize Kraton’s innovative products that are currently in development,” said Kim Sang-woo, vice chairman of DL Chemical, in a release Tuesday. “DL Chemical also plans to improve profitability of Kraton by applying DL Chemical’s managing capacity in operating manufacturing facilities and equipment.”
Kraton is a global petrochemical company, that has a number of proprietary technologies for manufacturing various chemical materials. It runs 13 manufacturing facilities globally and five research and development centers.
Its core products include styrene block copolymer (SBC), which is a thermoplastic elastomer often used in tubes, containers and food packaging.
The petrochemical company also manufactures bio chemicals utilizing byproducts from pine tree pulp.
"Through the latest acquisition, DL Chemical will internalize some core technologies that used to be monopolized by a few countries, including the United States, Japan and Germany," Vice Chairman Kim said.
BY JIN EUN-SOO [jin.eunsoo@joongang.co.kr]
Copyright © 코리아중앙데일리. 무단전재 및 재배포 금지.
- Phishing gang meets their match in teenaged girl
- CJ ENM and HYBE on the hunt for new girl group members
- After 512 episodes, Yumi and her cells say their final goodbye
- Korea to chair IAEA for first time
- Desire to retire young, rich catches FIRE
- Young people’s deaths after Pfizer vaccines are new worry
- ‘Squid Game’ is No. 1 among U.S. Netflix viewers
- In sick twist, 'Squid Game' is really a stock play
- Chipmakers balk at U.S. survey arguing information is secret
- Teens and pregnant women get ready for jabs